De Novo Myelodysplastic Syndrome clinical trials at UCSF
1 research study open to eligible people
De novo myelodysplastic syndrome is a blood cell disorder. UCSF is doing a trial on a drug called venetoclax with chemotherapy. It's for young people with blood diseases.
Venetoclax Basket Trial for High Risk Hematologic Malignancies
open to eligible people ages 1-40
This trial is evaluating the safety and tolerability of venetoclax with chemotherapy in pediatric and young adult patients with hematologic malignancies, including myelodysplastic syndrome (MDS), acute myeloid leukemia derived from myelodysplastic syndrome (MDS/AML), and acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL). The names of the study drugs involved in this study are below. Please note this is a list for the study as a whole, participants will receive drugs according to disease cohort. - Venetoclax - Azacitidine - Cytarabine - Methotrexate - Hydrocortisone - Leucovorin - Dexamethasone - Vincristine - Doxorubicin - Dexrazoxane - Calaspargase pegol - Hydrocortisone
San Francisco, California and other locations
Last updated: